Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Botulinum Toxin Treatment for Lower Limb Spasticity

Introduction to Botulinum Toxin Treatment

  • The American Academy of Otolaryngology-Head and Neck Surgery supports the use of botulinum toxin as an effective treatment for focal spasticity, causing transient, nondestructive flaccid paralysis by inhibiting acetylcholine release from nerve terminals, reducing muscle spasm 4, 5
  • Botulinum toxin treatment is considered standard of care for patients with focal lower limb spasticity who have failed conservative treatments, demonstrated positive response to previous injections, and have clear functional limitations that can be improved with treatment 1, 2

Medical Necessity Assessment

  • The patient, a 19-year-old male with a history of spasticity/dystonia, meets the clinical guideline criteria for botulinum toxin treatment, including being ≥2 years of age, having a primary diagnosis of lower limb spasticity/focal spasticity, and demonstrating benefit from previous Botox therapy 2, 3
  • The patient's current functional limitations, including difficulty with ambulation, walking on the outside of the right foot, and inability to achieve flat foot placement, can be improved with botulinum toxin treatment 2

Evidence for Botulinum Toxin in Spasticity Management

  • The evidence supports botulinum toxin as an effective treatment for focal spasticity, with treatment effects typically lasting 3-6 months, requiring periodic reinjection 1, 2, 4, 5
  • Botulinum toxin is particularly effective for ankle spasticity compared to oral medications, and can improve walking function and orthotic tolerance 2

Dosing and Administration Considerations

  • The requested dose of 400 units is within the appropriate range for lower limb spasticity, and the targeted muscles (right gastrocs, right soleus, right posterior tibialis) are appropriate for functional goals 2
  • The frequency of every 3 months aligns with the known duration of effect and clinical guidelines 4, 5

Safety Considerations

  • Botulinum toxin treatment is generally well-tolerated with mild to moderate transient adverse effects, and careful muscle selection and appropriate dosing minimize the risk of adverse effects 6

Treatment Goals and Expected Outcomes

  • The treatment goals for botulinum toxin treatment include decreasing focal hypertonicity and spasticity, reducing the risk for progressive contractures, increasing range of motion, and improving gait pattern and ability to achieve flat foot placement 2
  • The expected outcomes of botulinum toxin treatment include improved orthotic tolerance, optimized gross motor skills and mobility, and prevention of skin breakdown 2

REFERENCES

1

clinical practice guideline: hoarseness (dysphonia). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009

2

clinical practice guideline: hoarseness (dysphonia). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009

6

clinical practice guideline: hoarseness (dysphonia). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009